Comparison of two different schedules of granulocyte–colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen

Relation between the duration of remissi

Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate–cytarabine regimen

✍ Mary Ann Weiser; Maria E. Cabanillas; Marina Konopleva; Deborah A. Thomas; Sherr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

## Abstract ## BACKGROUND Hyperglycemia, which is not uncommon during the treatment of acute lymphocytic leukemia (ALL), has been shown to be an independent predictor of adverse outcomes among hospitalized patients with undiagnosed diabetes; it also may have the potential to affect leukemic cell p